Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTRX
426
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $31.3M | 0.06% |
513,166
-432,902
| -46% | -$26M |
|
427
HSBC
HSBC
$357B
| $31.3M | 0.06% |
+783,777
| New | +$32.6M |
|
428
DigitalBridge
DBRG
$2.95B
| $31.1M | 0.06% |
421,064
+36,221
| +9% | +$3.07M |
|
429
Automatic Data Processing
ADP
$112B
| $30.9M | 0.06% |
384,593
+219,125
| +132% | +$18.7M |
|
|
WR
430
DELISTED
Westar Energy Inc
WR
| $30.7M | 0.06% |
896,531
-704,264
| -44% | -$25.8M |
|
|
HR
431
DELISTED
Healthcare Realty Trust Incorporated
HR
| $30.7M | 0.06% |
1,318,087
+694,422
| +111% | +$17.4M |
|
432
Steel Dynamics
STLD
$32.9B
| $30.4M | 0.06% |
1,466,637
-2,357,032
| -62% | -$50.8M |
|
433
Antero Resources
AR
$11.7B
| $30.2M | 0.06% |
880,483
-685,137
| -44% | -$27.2M |
|
|
ANDV
434
DELISTED
Andeavor
ANDV
| $30.2M | 0.06% |
357,647
-276,154
| -44% | -$24M |
|
|
RAD
435
DELISTED
Rite Aid Corporation
RAD
| $30.2M | 0.06% |
180,719
-217,740
| -55% | -$36.5M |
|
436
Ralph Lauren
RL
$22.1B
| $30.2M | 0.06% |
227,841
-191,739
| -46% | -$25.9M |
|
|
GTLS
437
DELISTED
Chart Industries
GTLS
| $30M | 0.06% |
838,726
+131,820
| +19% | +$4.83M |
|
438
Honeywell
HON
$68.1B
| $30M | 0.06% |
327,151
+55,444
| +20% | +$5.17M |
|
|
SIAL
439
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $30M | 0.06% |
215,085
+29,186
| +16% | +$4.05M |
|
440
CALL
Bristol-Myers Squibb
BMY
$137B
| $29.9M | 0.06% |
+450,000
| New | +$29.7M |
|
|
BDN
441
Brandywine Realty Trust
BDN
$548M
| $29.7M | 0.06% |
2,235,791
+2,163,609
| +2,997% | +$31.3M |
|
442
Stanley Black & Decker
SWK
$14.9B
| $29.7M | 0.06% |
281,998
-379,364
| -57% | -$38.7M |
|
443
National Health Investors
NHI
$3.59B
| $29.7M | 0.06% |
476,113
+5,134
| +1% | +$343K |
|
444
Nexstar Media Group
NXST
$5.74B
| $29.6M | 0.06% |
528,328
+114,357
| +28% | +$6.56M |
|
445
JetBlue
JBLU
$1.87B
| $29.2M | 0.06% |
1,406,048
-611,372
| -30% | -$12.4M |
|
|
AKS
446
DELISTED
AK Steel Holding Corp
AKS
| $29.1M | 0.06% |
7,531,710
+3,205,874
| +74% | +$15.9M |
|
447
Kimco Realty
KIM
$16.2B
| $29M | 0.05% |
1,288,563
+400,596
| +45% | +$9.78M |
|
448
Carlisle Companies
CSL
$14.4B
| $29M | 0.05% |
289,657
-195,319
| -40% | -$19.2M |
|
|
ROIC
449
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $28.9M | 0.05% |
1,851,059
+758,967
| +69% | +$12.7M |
|
|
HIFR
450
DELISTED
InfraREIT, Inc.
HIFR
| $28.9M | 0.05% |
1,019,320
+455,526
| +81% | +$14.1M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.